Skip to content
High Tech Series A Founded 2021

CurifyLabs

Provider of digital 3D printing solutions for personalized medicine. The company has developed a platform that enables sustainable, quality-controlled production of personalized medicine through its pharmaceutical printing technology. It is a smart drug formulation platform that incorporates cutting-edge technology to redefine the drug compounding process. Founded in 2021, headquartered in Helsinki, Finland. The…

📍 Helsinki, Finland · 3D Printing,

Funding snapshot

Last roundSeries A
Amount$14M
Date6 July 2026
Total raised$34M
Team size42

About

Provider of digital 3D printing solutions for personalized medicine. The company has developed a platform that enables sustainable, quality-controlled production of personalized medicine through its pharmaceutical printing technology. It is a smart drug formulation platform that incorporates cutting-edge technology to redefine the drug compounding process. Founded in 2021, headquartered in Helsinki, Finland. The company has raised $33.8M in funding at the series a stage. CurifyLabs operates in the 3D Printing, Life Sciences Tech, Life Sciences Platforms and Tools sectors. The company focuses on Medicinal Pills, 3D Printing, 3D Bioprinting. Notable investors include EIC Fund, Europa, Springvest, Finpro, Sandwater, Healthcap, among others.

Business model

3D Printing > Applications > Healthcare > Medicinal Pills,

Life Sciences Tech > Manufacturing > 3D Printing,

Life Sciences Platforms and Tools > Instruments > 3D Bioprinting

Institutional investors

EIC Fund Europa Springvest Finpro Sandwater Healthcap Tesi Lifeline Ventures Health Incubator Helsinki Excedea

Backed by funds in our directory

Latest coverage

No articles yet.

Raising like CurifyLabs?

Analyze your pitch deck before your next raise.

Analyze My Deck →